2018-2019 AdooQ 最新目录册 点击此处下载

PI3K/Akt/mTOR 信号通路



产品 1 到 50 共 215个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序
Catalog No. Product Name Application Product Information
A12720

TIC10 isomer

AKT 抑制剂?€?
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics.
A13590

10-DEBC HCl

AKT/PKB 抑制剂?€?
10-DEBC HCl is a selective inhibitor of Akt/PKB. It inhibits IGF-1-stimulated phosphorylation and activation of Akt (complete inhibition at 2.5 μM), suppressing downstream activation of mTOR, p70 S6 kinase and S6 ribosomal protein.
A13554

SR-13668

AKT 抑制剂?€?
SR-13668 is an Akt inhibitor, is also an orally bioavailable indole-3-carbinol (I3C) analogue inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic and antiangiogenic activities.
A13030 SALE

Afuresertib HCl

AKT 抑制剂?€?
Afuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.
A15541 SALE

SC79

Akt phosphorylation activator
SC79 is an AKT activator. SC79 binds to the plecktrin homology (PH) domain of Akt that mimics the binding of PtdIns(3,4,5)P3 to induce a conformational change in Akt that enhances phosphorylation and activation.
A15809

GSK2141795 (Uprosertib, GSK795)

Akt 抑制剂
Akt inhibitor GSK2141795 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis.
A12081 SALE

SC 66

Akt 抑制剂
SC 66 is an allosteric inhibitor of Akt that facilitates both ubiquitination and deactivation of Akt. It exhibits anticancer activity in vitro and in vivo.
A15903

TIC10

Akt 抑制剂?€?
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
A16285

Akt1 and Akt2-IN-1

AKT 1/2 抑制剂
Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50 = 3.5 nM) and Akt2 (IC50 = 42 nM), with potent and balanced activity.
A16286

ARQ-092 (Miransertib)

AKT 抑制剂
ARQ 092 is an oral activie, potent and selective AKT inhibitor with IC50 values: 5.0 nM (AKT1); 4.5 nM (AKT2); 16 nM (AKT3).
A10003 SALE

MK-2206 2HCl

AKT 抑制剂
MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
A10709 SALE

Perifosine (NSC-639966)

Akt 抑制剂
Perifosine (also KRX-0401) acts as an Akt inhibitor and a PI3K inhibitor.
A11024 SALE

PF-04691502

PI3K/mTOR 抑制剂
PF-04691502 is a PI3K/mTOR kinase inhibitor, is also an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway.
A11030 SALE

GSK690693

AKT 抑制剂
GSK690693 is a novel ATP-competitive, low-nanomolar pan-Akt kinase inhibitor (IC50 values are 2, 13 and 9 nM of Akt1, 2 and 3 respectively).
A10094

AT7867

AKT 抑制剂
AT7867 is a novel and potent inhibitor of both AKT and the downstream kinase p70 S6 kinase (p70S6K) and also of protein kinase A.
A11031 SALE

CCT128930

AKT 抑制剂
CCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
A11032 SALE

PHT-427

AKT 抑制剂
PHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
A11033 SALE

Triciribine phosphate (NSC-280594)

AKT 抑制剂
Triciribine phosphate inhibits the phosphorylation, activation, and signalling of Akt-1, -2, and -3, which may result in the inhibition of Akt-expressing tumor cell proliferation.
A11034 SALE

A-674563

Akt 抑制剂
A-674563 is a B/Akt inhibitor with an IC50 of 14 nM and also shows inhibitory activity against PKA and CDK2 with IC50 of 16 and 46 nM, respectively.
A10453 SALE

Honokiol

Antiangiogenic and Antitumor Agent
Honokiol is a lignan present in the cones, bark, and leaves of Magnolia grandiflora that has shown pro-apoptotic effects in melanoma, sarcoma, myeloma, leukemia, bladder, lung, prostate, oral squamous cell carcinoma and colon cancer cell lines.
A11286 SALE

AKT inhibitor VIII (AKTI-1/2)

AKT 抑制剂
AKT inhibitor VIII is a cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 ?M for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays).
A11287 SALE

A-443654

Akt 抑制剂
A-443654, a specific Akt inhibitor with Ki value of 160 pM, interferes with mitotic progression and bipolar spindle formation.
A11759 SALE

AZD5363

AKT 抑制剂
AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.
A11246 SALE

GDC-0068 (Ipatasertib, RG-7440)

Akt 抑制剂
GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays
A12877

KP372-1

Akt 抑制剂
KP372-1 is a synthetic small molecule AKT inhibitor.
A13460 SALE

Deguelin

-
Deguelin is a natural product that displays profound antiproliferative activity.
A13210 SALE

Triciribine

AKT 抑制剂
Triciribine, also known as API-2, suppresses the phosphorylation level and kinase activity of Akt.
A12435

Akt-l-1

AKT1 抑制剂
Akt-I-1 is a specific inhibitor of Akt1 (IC(50) 4.6 µM) and does not inhibit AKT2, or AKT3
A12464

AT13148

multi-AGC kinase 抑制剂
AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.
A14138

Miltefosine

PI3K/Akt 抑制剂
Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa
A15006

AT7867 2HCl

Akt 抑制剂
AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively, little activity outside the AGC kinase family.
A16233

Tomatidine

ERK/Akt/NF-kB 抑制剂
Tomatidine inhibits the phosphorylation of ERK, Akt, and the nuclear content of NF-kB. possess anti-inflammatory properties.
A16392

Afuresertib

Akt 抑制剂
Afuresertib is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.
A12480 SALE

VS-5584

PI3K/mTOR 抑制剂
VS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
A13021 SALE

HS-173

PI3K 抑制剂
HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.
A14379

Panulisib (P7170, AK151761)

PI3K 抑制剂
Panulisib is a potent and selective imidazoquinoline based PI3K inhibitor with potential anticancer activity.
A14164 SALE

AZD8186

PI3K 抑制剂
AZD8186 is and inhibitor of the beta isoform of phosphoinositide-3 kinase (PI3K), with potential antineoplastic activity.
A15030

CAL-130

PI3K 抑制剂
CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).
A15031

CAL-130 Hydrochloride

PI3K 抑制剂
CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).
A15147

LY 303511

PI3K 抑制剂
LY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit PI3-K.
A15195

NVP-BKM120 Hydrochloride

PI3K 抑制剂?€?
NVP-BKM120 Hydrochloride is a selective PI3K inhibitor of p110??/??/??/?? with IC50 of 52 nM/166 nM/116 nM/262 nM, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4K??.
A15212

PI-103 Hydrochloride

PI3K 抑制剂
PI103 is a potent inhibitor with low IC50 values against recombinant PI3K isoforms p110alpha (IC50= 2 nM), p110beta (IC50= 3 nM), p110delta (IC50= 3 nM), and p110gamma (IC50= 15 nM), less potent to mTOR/DNA-PK with IC50 of 30 nM/23 nM.
A15283

XL-147 (Pilaralisib)

PI3K 抑制剂
XL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases.
A15759 SALE

AZD8186

PI3K 抑制剂
AZD8186 is an isoform-specific small-molecule PI3K inhibitor, potently inhibits PI3Kβ (IC50=4 nM) and PI3Kδ (IC50=12 nM) with selectivity over PI3Kα (IC50=35 nM) and PI3Kγ (IC50=675 nM).
A14441

Acalisib (GS-9820)

PI3K?? 抑制剂
Acalisib is an inhibitor of the beta and delta isoforms of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities.
A15901

AMG319

PI3K?? 抑制剂
AMG319 is a potent and selective PI3Kδ inhibitor with IC50 of 18 nM, >47-fold selectivity over other PI3Ks. Phase 2.
A12889

PF-4989216

PI3K 抑制剂
PF-4989216 is a potent and selective PI3K inhibitor with IC50 of 2 nM, 142 nM, 65 nM, 1 nM, and 110 nM for p110??, p110??, p110??, p110??, and VPS34, respectively.
A15992

PQR309

PI3K 抑制剂
PQR309 is an orally bioavailable pan inhibitor of phosphoinositide-3-kinases (PI3K) and inhibitor of the mammalian target of rapamycin (mTOR), with potential antineoplastic activity.
A13992

GNE-317

PI3K 抑制剂
GNE-317 is a potent PI3K inhibitor that can cross the Blood brain barrier; shows potent suppression of the PI3K pathway in the brain of mice with intact BBB.
A16126

LY3023414

PI3K/mTOR Dual 抑制剂
LY3023414 is an oral ATP competitive inhibitor of the class I PI3K isoforms, mTOR and DNA-PK, extracted from patent WO/2012097039A1, compound example 1, has an IC50 of 64.9 nM, 42.1 nM, 10.6 nM, 19.1 nM for Akt1(pT308), Akt1 (pS473), P70S6(pT389), S6RP(pS240/242).

产品 1 到 50 共 215个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序